Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-10 · accession 0001628280-25-012005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-11 | 2025-03-10 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +35.0K | 1.01M | +4% | $0 |
| D | 2025-03-11 | 2025-03-10 | SUPN | Khattar Jack A. | Pres, CEO, Dir | F - Tax | $32.06 | -16.8K | 991.8K | -2% | -$538.8K |
| D | 2025-03-11 | 2025-03-10 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | -35.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-10 | M | A | 35,000 | $0.00 | 1,008,638 | D | — | — | (F1) Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023. |
| 2 | Common | Common Stock | 2025-03-10 | F | D | 16,805 | $32.06 | 991,833 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 3 | Derivative | Performance Share Unit | 2025-03-10 | M | D | 35,000 | $0.00 | 0 | D | $0.00 · — to — | 35,000 Common Stock | (F3) On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. |